Market revenue in 2023 | USD 19,349.1 million |
Market revenue in 2030 | USD 47,496.7 million |
Growth rate | 13.7% (CAGR from 2023 to 2030) |
Largest segment | Tablets |
Fastest growing segment | Liquid Oral |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Tablets, Capsules, Liquid Oral, Powder In Sachet / Jar, Gummies, Energy Bars, Other suitable forms (Diskettes, etc.) |
Key market players worldwide | Ashland Inc, Glanbia PLC, Herbalife Ltd, Menadiona, Twinlab Consolidated Holdings Inc, Nutrivo, Gemini Pharmaceuticals, Rain Nutrience |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to nutraceutical contract manufacturing services market will help companies and investors design strategic landscapes.
Tablets was the largest segment with a revenue share of 25.27% in 2023. Horizon Databook has segmented the China nutraceutical contract manufacturing services market based on tablets, capsules, liquid oral, powder in sachet / jar, gummies, energy bars, other suitable forms (diskettes, etc.) covering the revenue growth of each sub-segment from 2018 to 2030.
In China, nutrient supplements are regulated as a subcategory of health food. Nutrient supplements complement nutrients such as vitamins and minerals rather than providing energy. The roles of nutrient supplements include disease risk mitigation, nutritional deficiency prevention, and supplementation of insufficient dietary intakes.
Before being sold in China, all imported health supplements are subject to approval by the State Administration for Market Regulation (SAMR). Manufacturers are required to produce Research & Development (R&D) reports with significant data, product formulas, manufacturing processes, and reviews of safety & function.
The rising prevalence of chronic diseases and lifestyle-related health issues have made consumers more conscious about their health. Nutraceuticals are perceived as a natural and preventive solution to address these concerns, driving the demand in China. Moreover, the government in China has recognized the potential of the nutraceuticals industry and has implemented policies to support its growth.
Horizon Databook provides a detailed overview of country-level data and insights on the China nutraceutical contract manufacturing services market , including forecasts for subscribers. This country databook contains high-level insights into China nutraceutical contract manufacturing services market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account